Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Premaitha pushing on in spite of Illumina prenatal testing patent lawsuit

This article was originally published in Clinica

Executive Summary

UK noninvasive prenatal testing specialist Premaitha Health has been dealt a blow after larger rival Illumina sued it for patent infringement. But while Premaitha CEO Stephen Little described the development as a “nuisance,” he is confident that the firm’s technology does not infringe any third-party IP, he told Clinica.


Related Content





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts